GlassScriptPhysician profile
Angela B Mebane
NPI 1043203797
$835.43
in general payments reported to CMS, 2019-2025
18 companies · $66.83 in 2025
The $66.83 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $91.32 · 2022: $14.03 · 2023: $82.11 · 2024: $426 · 2025: $66.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $140.69 | 2019-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $121.72 | 2019-2024 | Jardiance, Zepbound, Mounjaro |
| Novartis Pharmaceuticals Corporation | $99.44 | 2019-2024 | |
| Novo Nordisk INC | $94.42 | 2019-2024 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $51.85 | 2019-2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $44.59 | 2020-2024 | Airsupra |
| Dynavax Technologies Corporation | $43.66 | 2024 | Heplisav-B |
| Merck Sharp & Dohme LLC | $36.75 | 2019 | |
| Shield Therapeutics INC | $33.36 | 2024 | |
| Pfizer INC. | $31.74 | 2019-2020 | |
| Eisai INC. | $21.49 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $21.34 | 2025 | Camzyos |
| Abbvie INC. | $19.39 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.51 | 2025 | Xifaxan |
| Shire North American Group INC | $15.09 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $15.04 | 2024 | Dexcom G6 Transmitter |
| Masimo Corporation | $14.32 | 2024 | Sedline |
| Sanofi Pasteur INC. | $14.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Mebane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.